148 related articles for article (PubMed ID: 32424618)
1. De novo mutations in FBRSL1 cause a novel recognizable malformation and intellectual disability syndrome.
Ufartes R; Berger H; Till K; Salinas G; Sturm M; Altmüller J; Nürnberg P; Thiele H; Funke R; Apeshiotis N; Langen H; Wollnik B; Borchers A; Pauli S
Hum Genet; 2020 Nov; 139(11):1363-1379. PubMed ID: 32424618
[TBL] [Abstract][Full Text] [Related]
2. Fbrsl1 is required for heart development in Xenopus laevis and de novo variants in FBRSL1 can cause human heart defects.
Berger H; Gerstner S; Horstmann MF; Pauli S; Borchers A
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38501224
[TBL] [Abstract][Full Text] [Related]
3. Comparing a Novel Malformation Syndrome Caused by Pathogenic Variants in
Pauli S; Berger H; Ufartes R; Borchers A
Front Cell Dev Biol; 2021; 9():779009. PubMed ID: 34805182
[TBL] [Abstract][Full Text] [Related]
4. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
Beunders G; Voorhoeve E; Golzio C; Pardo LM; Rosenfeld JA; Talkowski ME; Simonic I; Lionel AC; Vergult S; Pyatt RE; van de Kamp J; Nieuwint A; Weiss MM; Rizzu P; Verwer LE; van Spaendonk RM; Shen Y; Wu BL; Yu T; Yu Y; Chiang C; Gusella JF; Lindgren AM; Morton CC; van Binsbergen E; Bulk S; van Rossem E; Vanakker O; Armstrong R; Park SM; Greenhalgh L; Maye U; Neill NJ; Abbott KM; Sell S; Ladda R; Farber DM; Bader PI; Cushing T; Drautz JM; Konczal L; Nash P; de Los Reyes E; Carter MT; Hopkins E; Marshall CR; Osborne LR; Gripp KW; Thrush DL; Hashimoto S; Gastier-Foster JM; Astbury C; Ylstra B; Meijers-Heijboer H; Posthuma D; Menten B; Mortier G; Scherer SW; Eichler EE; Girirajan S; Katsanis N; Groffen AJ; Sistermans EA
Am J Hum Genet; 2013 Feb; 92(2):210-20. PubMed ID: 23332918
[TBL] [Abstract][Full Text] [Related]
5. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
[TBL] [Abstract][Full Text] [Related]
6. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.
Fan Y; Yin W; Hu B; Kline AD; Zhang VW; Liang D; Sun Y; Wang L; Tang S; Powis Z; Li L; Yan H; Shi Z; Yang X; Chen Y; Wang J; Jiang Y; Tan H; Gu X; Wu L; Yu Y
Am J Hum Genet; 2018 Sep; 103(3):448-455. PubMed ID: 30122539
[TBL] [Abstract][Full Text] [Related]
7. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
8. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype.
Beunders G; van de Kamp J; Vasudevan P; Morton J; Smets K; Kleefstra T; de Munnik SA; Schuurs-Hoeijmakers J; Ceulemans B; Zollino M; Hoffjan S; Wieczorek S; So J; Mercer L; Walker T; Velsher L; ; Parker MJ; Magee AC; Elffers B; Kooy RF; Yntema HG; Meijers-Heijboer EJ; Sistermans EA
J Med Genet; 2016 Aug; 53(8):523-32. PubMed ID: 27075013
[TBL] [Abstract][Full Text] [Related]
9. Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome.
Hempel A; Pagnamenta AT; Blyth M; Mansour S; McConnell V; Kou I; Ikegawa S; Tsurusaki Y; Matsumoto N; Lo-Castro A; Plessis G; Albrecht B; Battaglia A; Taylor JC; Howard MF; Keays D; Sohal AS; ; Kühl SJ; Kini U; McNeill A
J Med Genet; 2016 Mar; 53(3):152-62. PubMed ID: 26543203
[TBL] [Abstract][Full Text] [Related]
10. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
[TBL] [Abstract][Full Text] [Related]
11. Novel truncating PPM1D mutation in a patient with intellectual disability.
Porrmann J; Rump A; Hackmann K; Di Donato N; Kahlert AK; Wagner J; Jahn A; Eger I; Flury M; Schrock E; Tzschach A; Gieldon L
Eur J Med Genet; 2019 Jan; 62(1):70-72. PubMed ID: 29758292
[TBL] [Abstract][Full Text] [Related]
12. De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome.
Jansen S; Geuer S; Pfundt R; Brough R; Ghongane P; Herkert JC; Marco EJ; Willemsen MH; Kleefstra T; Hannibal M; Shieh JT; Lynch SA; Flinter F; FitzPatrick DR; Gardham A; Bernhard B; Ragge N; Newbury-Ecob R; Bernier R; Kvarnung M; Magnusson EA; Wessels MW; van Slegtenhorst MA; Monaghan KG; de Vries P; Veltman JA; ; Lord CJ; Vissers LE; de Vries BB
Am J Hum Genet; 2017 Apr; 100(4):650-658. PubMed ID: 28343630
[TBL] [Abstract][Full Text] [Related]
13. AUTS2 isoforms control neuronal differentiation.
Monderer-Rothkoff G; Tal N; Risman M; Shani O; Nissim-Rafinia M; Malki-Feldman L; Medvedeva V; Groszer M; Meshorer E; Shifman S
Mol Psychiatry; 2021 Feb; 26(2):666-681. PubMed ID: 30953002
[TBL] [Abstract][Full Text] [Related]
14. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
15. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
[TBL] [Abstract][Full Text] [Related]
16. Novel truncating variants expand the phenotypic spectrum of KAT6B-related disorders.
Brea-Fernández A; Dacruz D; Eirís J; Barros F; Carracedo Á
Am J Med Genet A; 2019 Feb; 179(2):290-294. PubMed ID: 30569622
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.
Stankiewicz P; Khan TN; Szafranski P; Slattery L; Streff H; Vetrini F; Bernstein JA; Brown CW; Rosenfeld JA; Rednam S; Scollon S; Bergstrom KL; Parsons DW; Plon SE; Vieira MW; Quaio CRDC; Baratela WAR; Acosta Guio JC; Armstrong R; Mehta SG; Rump P; Pfundt R; Lewandowski R; Fernandes EM; Shinde DN; Tang S; Hoyer J; Zweier C; Reis A; Bacino CA; Xiao R; Breman AM; Smith JL; ; Katsanis N; Bostwick B; Popp B; Davis EE; Yang Y
Am J Hum Genet; 2017 Oct; 101(4):503-515. PubMed ID: 28942966
[TBL] [Abstract][Full Text] [Related]
18. Isolated loss of the AUTS2 long isoform, brain-wide or targeted to Calbindin-lineage cells, generates a specific suite of brain, behavioral, and molecular pathologies.
Song Y; Seward CH; Chen CY; LeBlanc A; Leddy AM; Stubbs L
Genetics; 2024 Jan; 226(1):. PubMed ID: 37816306
[TBL] [Abstract][Full Text] [Related]
19. Exonic deletions of AUTS2 in Chinese patients with developmental delay and intellectual disability.
Fan Y; Qiu W; Wang L; Gu X; Yu Y
Am J Med Genet A; 2016 Feb; 170A(2):515-522. PubMed ID: 26545289
[TBL] [Abstract][Full Text] [Related]
20. Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.
Kuechler A; Czeschik JC; Graf E; Grasshoff U; Hüffmeier U; Busa T; Beck-Woedl S; Faivre L; Rivière JB; Bader I; Koch J; Reis A; Hehr U; Rittinger O; Sperl W; Haack TB; Wieland T; Engels H; Prokisch H; Strom TM; Lüdecke HJ; Wieczorek D
Eur J Hum Genet; 2017 Feb; 25(2):183-191. PubMed ID: 27901041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
